Article

Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025

2025-04-25

Abstract excerpt

Respiratory syncytial virus (RSV) presents a significant health risk to young infants and substantially burdens already stretched health systems every winter. Ireland launched a RSV immunisation pathfinder programme for newborns and other clinically vulnerable infants in September of 2024. While a comprehensive evaluation of the programme is underway, we aimed to rapidly analyse the impact of the programme on infa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2b55d0a6-ca52-5c98-a89d-a90d21cf8c46
DOI: 10.1101/2025.04.23.25326289

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025DOI 10.1101/2025.04.23.25326289Read

Respiratory syncytial virus (RSV) notifications and trends in the transmission cycles from infants and young children to older adults in Ireland: an analysis of incidence shifts over a decadeSemantic proximity Read

The Epidemiology of Respiratory Syncytial Virus in Children Under Five Years-Old During the COVID-19 Pandemic Measured by Laboratory, Clinical and Syndromic Surveillance in England: A Retrospective Observational Study Including the 2020/21 Winter SeasonSemantic proximity Read

Epidemiological Study of Post-Pandemic Pediatric Common Respiratory Pathogens using Multiplex DetectionSemantic proximity Read

Respiratory syncytial virus in pediatric patients with severe acute respiratory infections in Senegal: findings from the 2022 sentinel surveillance season.Semantic proximity Read

Population Impact of a hybrid strategy combining maternal RSV vaccination and nirsevimab immunization on lower respiratory tract infections in infants under 1 year in Bogotá: a counterfactual analysisSemantic proximity Read

Respiratory syncytial virus hospitalisations among young children: a data linkage studySemantic proximity Read

Clinical and economic burden of Respiratory Syncytial Virus in children aged 0-5 years in ItalySemantic proximity Read

Respiratory syncytial virus (RSV) in an Italian pediatric cohort: genomic analysis and circulation pattern in the season 2022-2023Semantic proximity Read

The burden of RSV-associated illness in children aged <5 years, South Africa, 2011 to 2016Semantic proximity Read

Early initiation of the respiratory syncytial virus season in 2021-2022, Greece.Semantic proximity Read

SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohortSemantic proximity Read

Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemicSemantic proximity Read